Red blood cell volume distribution width (RDW) was obtained with the Coulter counter in 60 haemodialysis patients and 55 normal individuals. RDW tended to be higher in the former and the degree of increase was to some extent correlated with the underlying nephropathy. Although RDW failed to correlate with conventional tests of iron status, it was observed that iron administration could produce a decrease toward normal in RDW and a parallel increase in haemoglobin when the initial RDW was increased. In contrast, the response to iron was negligible in the patients with normal RDW basally. It was concluded that high RDW is an acceptable indicator of iron deficiency in haemodialysis patients.
Coulter Electronics, Inc.Instructions arid service manual for the Coulter counter. Hialeah, Fla., USA, 1982.
2.
BessmanJD, RidgwayPG, GardnerFH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol1983; 80:322–6.
3.
BaynesRD, FlaxH, BothwellTH, BezwodaWR, AtkinsonP, MendelowB.Red blood cell distribution width in the anemia secondary to tuberculosis. Am J Clin Pathol1986; 85:226–9.
4.
EschbachJW. Hematologic problems of dialysis patients. In: DrukkerW, ParsonsFM, MaherJF, eds. Replacement of renal function by dialysis.Boston: Nijhoff, 1983; 630–45.
5.
MorebJ, PopovitzerMM, FriedlanderMM, KonijnAM, HershkoC.Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume, and red cell protoporphyrin. Nephron1983; 35:196–200.
6.
DocciD, CenciottiL, TurciF, SalviG, MosconiG, BaldratiL.Ferritina sierica e terapia marziale nei pazienti in emodialisi periodica. Quad Sclavo Diagn1982; 18:454–62.
7.
BessmanJD, JohnsonRK. Erythrocyte volume distribution in normal and abnormal subjects. Blood1975; 46:369–79.
8.
McDonaldME, SmyrkTC, PayneBA, PierreRV. Evaluation of the concept of the classification of anemias by use of the RDW/MCV. Blood1984; 64(suppl):45a–50a.
9.
HampersCL, StreiftR, NathanDG, SnyderD, MerrilJP. Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. New Engl J Med1967; 276:551–4.
10.
WhiteheadVM, ComtyCH, PosenGA, KayeM.Homeostasis of folic acid in patients undergoing maintenance hemodialysis. New Eng J Med1968; 279:970–2.
11.
Hemmeloff AndersenKE. Folic acid status in patients with chronic renal failure maintained by dialysis. Clin Nephrol1977; 8:510–3.
HallidayJW, PowellLW. Serum ferritin and isoferritins in clinical medicine. Prog Hemat1979; 11:229–66.
14.
AliM, RigolosiR, FayemiAO, BraunEV, FrascinoJ, SingerR.Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy. Lancet1982; 1:652–5.
15.
MirhamadiMK, VaziriND. Value of serum ferritin determination in hemodialysis patients (Editorial). Int J Artif Organs1980; 3:318–9.
16.
WardMK, ParkinsonsIS. Aluminium toxicity in renal failure. In: DrukkerW, ParsonsFM, MaherJF, eds. Replacement of renal failure by dialysis.Boston: Nijhoff, 1983; 811–9.
17.
ComtyCM, ShapiroFL. Pretreatment and preparation of city water for dialysis. In: DrukkerW, ParsonsFM, MaherJF, eds. Replacement of renal failure by dialysis.Boston: Nijoff, 1983; 142–7.
18.
McGonigleRJS, ParsonsV.Aluminium-induced anemia in hemodialysis patients. Nephron1985; 39:1–9.
